These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

980 related items for PubMed ID: 3722324

  • 21. Effects of oral contraceptives on plasma neutral amino acids and cholesterol during a menstrual cycle.
    Moller SE, Moller BM, Olesen M, Fjalland B.
    Eur J Clin Pharmacol; 1996; 50(3):179-84. PubMed ID: 8737756
    [Abstract] [Full Text] [Related]

  • 22. Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle.
    Chaireti R, Gustafsson KM, Byström B, Bremme K, Lindahl TL.
    Hum Reprod; 2013 Jul; 28(7):1846-52. PubMed ID: 23592222
    [Abstract] [Full Text] [Related]

  • 23. Oral contraceptives alter circadian rhythm parameters of cortisol, melatonin, blood pressure, heart rate, skin blood flow, transepidermal water loss, and skin amino acids of healthy young women.
    Reinberg AE, Touitou Y, Soudant E, Bernard D, Bazin R, Mechkouri M.
    Chronobiol Int; 1996 Aug; 13(3):199-211. PubMed ID: 8874983
    [Abstract] [Full Text] [Related]

  • 24. Pregnancy-specific beta 1-glycoprotein and chorionic gonadotropin-like immunoreactivity during the latter half of the cycle in women using intrauterine contraception.
    Seppälä M, Rutanen EM, Jalanko H, Lehtovirta P, Stenman UH, Engvall E.
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1216-9. PubMed ID: 318094
    [Abstract] [Full Text] [Related]

  • 25. Hormonal profile in IUD users.
    Souka AR, Rahman H, Osman M, Mohei Y, Rizk M.
    Contracept Deliv Syst; 1981 Oct; 2(4):303-10. PubMed ID: 12336991
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
    Hale GE, Hughes CL, Burger HG, Robertson DM, Fraser IS.
    Menopause; 2009 Oct; 16(1):50-9. PubMed ID: 18978637
    [Abstract] [Full Text] [Related]

  • 28. Nocturnal slowing of pulsatile luteinizing hormone secretion in women during the follicular phase of the menstrual cycle.
    Soules MR, Steiner RA, Cohen NL, Bremner WJ, Clifton DK.
    J Clin Endocrinol Metab; 1985 Jul; 61(1):43-9. PubMed ID: 3923031
    [Abstract] [Full Text] [Related]

  • 29. Circadian rhythms, sleep, and the menstrual cycle.
    Baker FC, Driver HS.
    Sleep Med; 2007 Sep; 8(6):613-22. PubMed ID: 17383933
    [Abstract] [Full Text] [Related]

  • 30. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
    Hemrika DJ, Slaats EH, Kennedy JC, de Vries Robles-Korsen TJ, Schoemaker J.
    J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
    [Abstract] [Full Text] [Related]

  • 31. Sleep and 24 hour body temperatures: a comparison in young men, naturally cycling women and women taking hormonal contraceptives.
    Baker FC, Waner JI, Vieira EF, Taylor SR, Driver HS, Mitchell D.
    J Physiol; 2001 Feb 01; 530(Pt 3):565-74. PubMed ID: 11158285
    [Abstract] [Full Text] [Related]

  • 32. Value of subcutaneous fat in predicting ovulation day.
    Jamaludin J, Nordin NM, Mohamad N, Etta KM.
    Malays J Reprod Health; 1988 Jun 01; 6(1):65-9. PubMed ID: 12281593
    [Abstract] [Full Text] [Related]

  • 33. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH, Walden CE, Wahl PW, Hoover JJ, Warnick GR, Albers JJ, Ogilvie JT, Hazzard WR.
    J Clin Endocrinol Metab; 1981 Dec 01; 53(6):1123-32. PubMed ID: 7298796
    [Abstract] [Full Text] [Related]

  • 34. Luteal phase deficiency: abnormal gonadotropin and progesterone secretion patterns.
    Soules MR, Clifton DK, Cohen NL, Bremner WJ, Steiner RA.
    J Clin Endocrinol Metab; 1989 Oct 01; 69(4):813-20. PubMed ID: 2506215
    [Abstract] [Full Text] [Related]

  • 35. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH, Garzo G, Morris S, Stuenkel C, Ulmann A, Yen SS.
    J Clin Endocrinol Metab; 1987 Dec 01; 65(6):1135-40. PubMed ID: 2824550
    [Abstract] [Full Text] [Related]

  • 36. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB, Salvatierra AM, Romero C, Spitz IM.
    J Clin Endocrinol Metab; 1987 Dec 01; 65(6):1272-7. PubMed ID: 3119656
    [Abstract] [Full Text] [Related]

  • 37. The effect of the phase of the menstrual cycle and the birth control pill on athletic performance.
    Lebrun CM.
    Clin Sports Med; 1994 Apr 01; 13(2):419-41. PubMed ID: 8013042
    [Abstract] [Full Text] [Related]

  • 38. Reduced phase-advance of plasma melatonin after bright morning light in the luteal, but not follicular, menstrual cycle phase in premenstrual dysphoric disorder: an extended study.
    Parry BL, Meliska CJ, Sorenson DL, Martínez LF, López AM, Elliott JA, Hauger RL.
    Chronobiol Int; 2011 May 01; 28(5):415-24. PubMed ID: 21721857
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 49.